SUPERNUS PHARMACEUTICALS, INC.
Ticker: 1356576
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 219.06+5.5% | 207.71+8.1% | 192.10+16.1% | 165.45+10.4% | 149.82-14.7% | 175.69+4.4% | 168.33+17.2% | 143.64 |
| Total Income | 219.06+5.5% | 207.71+8.1% | 192.10+16.1% | 165.45+10.4% | 149.82-14.7% | 175.69+4.4% | 168.33+17.2% | 143.64 |
| EXPENSES | ||||||||
| Expenditure | 277.02+28.2% | 216.04-14.4% | 252.33+64.6% | 153.31-4.2% | 160.08+18.7% | 134.84-7.5% | 145.76-0.7% | 146.80 |
| Tax | 0.72+119.7% | -3.66+71.5% | -12.84-120.2% | -5.83-197.2% | 6.00-7.0% | 6.45+0.9% | 6.39+5225.0% | 0.12 |
| PROFIT | ||||||||
| PBT | -57.65-868.9% | -5.95+89.7% | -57.95-447.6% | 16.67+385.9% | -5.83-113.0% | 44.94+70.9% | 26.30+10858.3% | 0.24 |
| Net Profit | -58.37-2448.9% | -2.29+94.9% | -45.12-300.5% | 22.50+290.2% | -11.83-130.7% | 38.50+93.3% | 19.92+16500.0% | 0.12 |
| KEY METRICS | ||||||||
| OPM % | -26.46%-22.45pp | -4.01%+27.34pp | -31.35%-38.69pp | 7.34%+14.18pp | -6.84%-30.09pp | 23.25%+9.84pp | 13.41%+15.60pp | -2.19% |
| NPM % | -26.65%-25.54pp | -1.10%+22.38pp | -23.49%-37.08pp | 13.60%+21.49pp | -7.89%-29.81pp | 21.91%+10.08pp | 11.83%+11.75pp | 0.09% |
| EPS | -1.01-2425.0% | -0.04+95.0% | -0.80-300.0% | 0.40+290.5% | -0.21-130.0% | 0.70+94.4% | 0.36 | 0.00 |
Corporate Events
Board MeetingSUPN
202615Oct
Board Meeting
Supernus Pharmaceuticals, Inc. held a special meeting of its…
SEC Filing ↗ Board MeetingSUPN
20261Aug
Board Meeting
Merger Agreement between Supernus Pharmaceuticals and Indivi…
SEC Filing ↗ Board MeetingSUPN
202618Jun
Board Meeting
Annual Meeting of Stockholders voting results, including the…
SEC Filing ↗